The combination therapy with EpCAM/CD3 BsAb and MUC-1/CD3 BsAb elicited antitumor immunity by T-cell adoptive immunotherapy in lung cancer

Lung cancer remains a global challenge due to high morbidity and mortality rates and poor response to treatment, and there are still no effective strategies to solve it. The bispecific antibody (BsAb) is a novel antibody, which can target two different antigens and mediate specific killing effects b...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ce, Chen, Shang, Wu, Yingjuan, Wu, Di, Wang, Jingbo, Li, Furong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436090/
https://www.ncbi.nlm.nih.gov/pubmed/34522164
http://dx.doi.org/10.7150/ijms.61681

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436090/
https://www.ncbi.nlm.nih.gov/pubmed/34522164
http://dx.doi.org/10.7150/ijms.61681

Ejemplares similares